VISTAGEN THERAPEUTICS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Exercise Price
VISTAGEN THERAPEUTICS, INC. (VTGN) had Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Exercise Price of $1.27 per share as of 2021-03-31, per its 10-K filed 2021-06-29.
Discontinued › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice · last filed 2021-06-29
- 2021-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Exercise Price $1.27.
- 2020-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Exercise Price $1.14.
- 2019-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Exercise Price $2.43.
- 2019-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Exercise Price $2.53.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Exercise Price |
|---|---|
| 2021-03-31 | $1.27 10-K · filed 2021-06-29 |
| 2020-03-31 | $1.14 10-K · filed 2021-06-29 |
| 2019-09-30 | $2.43 10-Q · filed 2019-11-07 |
| 2019-06-30 | $2.53 10-Q · filed 2019-08-13 |
| 2019-03-31 | $1.45 10-K · filed 2020-06-29 |
| 2018-12-31 | $2.54 10-Q · filed 2019-02-12 |
| 2018-09-30 | $1.27 10-Q · filed 2018-10-29 |
| 2018-03-31 | $1.44 10-K · filed 2019-06-25 |
| 2017-03-31 | $3.69 10-K · filed 2018-06-26 |
| 2016-03-31 | $8.78 10-K · filed 2017-06-29 |
| 2015-12-31 | $7.81 10-Q · filed 2016-02-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B |